Filing Flows › Calumet (CLMT) › Q2 2026 › vs Q1 2026
Calumet (CLMT) Q2 2026 vs Q1 2026 (quarter over quarter)
Calumet's revenue rose $415M (+40%) from $1.0B in Q1 2026 to $1.4B in Q2 2026.
Calumet, Q2 2026: revenue $1.4B (+41% year over year), operating margin -2.8%, net loss $95.9M, operating cash flow $92.3M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Free cash flow margin | 3.7% | -9.7% | +13.4 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $1.4B | $1.0B | $415M | +40% |
| Income tax benefit | $21.2M | $20.8M | $400K | +2% |
| Net loss | $95.9M | $317M | −$221M | -70% |
| Costs & expenses | $1.6B | $1.4B | $195M | +14% |
| Operating costs | $1.5B | $1.2B | $284M | +24% |
| Interest & other, net | $77.1M | $166M | −$89.4M | -54% |
| Cost of revenue | $1.4B | $1.1B | $310M | +28% |
| Sales & marketing | $13.5M | $12.3M | $1.2M | +10% |
| General & admin | $39.4M | $66.0M | −$26.6M | -40% |
| Other operating costs | $5.4M | $5.5M | −$100K | -2% |
| Operating cash sources | $188M | $231M | −$42.6M | -18% |
| Depreciation & amortization | $34.6M | $33.0M | $1.6M | +5% |
| Share-based compensation | $7.5M | $37.4M | −$29.9M | -80% |
| Working capital & other | $146M | $160M | −$14.3M | -9% |
| Net loss absorbed | $95.9M | $317M | −$221M | -70% |
| Operating cash flow | $92.3M | −$86.2M | $178M | — |
| Free cash flow (OCF − capex) | $54.0M | −$99.4M | $153M | — |
| Capital expenditures | $38.3M | $13.2M | $25.1M | +190% |
Questions
How much did Calumet's revenue grow quarter over quarter in Q2 2026?
Calumet's revenue rose $415M (+40%) from $1.0B in Q1 2026 to $1.4B in Q2 2026.